Guest guest Posted March 2, 2008 Report Posted March 2, 2008 Ralph W. Moss, Ph.D. Weekly CancerDecisions.com Newsletter #330 03/02/08 THE MOSS REPORTS - CANCER DECISIONS NEWSLETTER A BAD DECISION ON AVASTIN On Friday, Feb. 22, 2008, top administrators of the Food and Drug Administration (FDA) approved the drug Avastin for the treatment of advanced breast cancer. Avastin, which has already been approved for colon and lung cancer, is controversial because it has never been shown to extend overall survival (OS) in breast cancer patients. To read or listen to this week's newsletter, please go to: http://www.cancerdecisions.com/030208.html [and scroll down page] Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.